As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially Omicron, have developed ways to evade the antibodies we make in response to vaccines. A new, broadly neutralizing antibody developed at Boston Children’s Hospital could potentially improve our ability to defend against future variants.
Powerful new antibody neutralizes all known SARS-CoV-2 variants
August 18, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022